NEWS FLASH:
- 2019-01: Meet us at these upcoming 2019 conferences:
- Laborforum, Hannover (Germany) - 30 JAN - together with the HITADO-SYSMEX team
- GTH, Berlin (Germany) - 27 FEB - 2 MAR - DOASENSE booth & lunch symposium [PROGRAMME]
- POCT Symposium, Munich (Germany) - 11-13 MAR - together with the HITADO-SYSMEX team (SYSMEX booth)
- DAC, Leipzig (Germany) - 9-11 MAY - together with the HITADO-SYSMEX team (SYSMEX booth)
- Laborforum, Dortmund (Germany) - 26 JUNE - together with the HITADO-SYSMEX team
- ISTH, Melbourne (Australia) - 6-10 JULY - DOASENSE booth
- 2018-11: The DOAC Dipstick point-of-care test is now commercially available in Germany through HITADO [ORDER HERE] / Der DOAC Dipstick Point-of-Care-Test ist nun in Deutschland über HITADO erhältlich [BESTELLEN SIE HIER]
- 2018-09: First peer-reviewed paper on our DOAC Dipstick point-of-care test has recently been published in Seminars in Thrombosis & Hemostasis
[Free open access download of the epub ahead of print HERE]
More News [HERE]
When every minute counts … fast DOAC testing matters.
DOASENSE’s mission objective is changing the landscape of testing for DOACs (new synthetic oral anticoagulants) with novel and quick point-of-care urine tests
The determination of DOACs has long been limited to blood sampling approaches, with all their potential limitations, and a rapid assessment of the anticoagulant effect of non-vitamin K antagonist oral anticoagulants (Direct Oral AntiCoagulants – DOACs) by point-of-care testing (POCT) so far has been an unmet clinical need.
DOASENSE develops products for specific testing for DOACs in urine
Tests which are easy to use and easy to interpret, reproducible, and patient friendly
Listen to what opinion leaders think about DOASENSE's solutions:
Typical clinical scenarios where testing for specific DOACs can be of value
- Stroke (e.g. before thrombolytic therapy)
- Trauma
- Emergency procedures
- Evaluating for venous thromboembolism
- Spontaneous hemorrhage
- General surgery or invasive procedures
- Other situations where medication history may not available
In each of these situations the objective is establishing the absence of DOACs in the patient prior to procedure
NOTE: DOASENSE(TM) products may not be available or approved in your country.